Huttunen M, Lampainen E, Lilja M, Ikäheimo M, Kontro J, Mäkynen P, Savolainen A
Hospital of Internal Medicine, Kuopio, Finland.
J Hum Hypertens. 1992 Apr;6(2):121-5.
Thirty-eight patients already treated with atenolol 50 mg once daily were randomly assigned to treatment with either hydrochlorothiazide (12.5-25 mg once daily) or lisinopril (10-20 mg once daily) for 8 weeks in a double-blind crossover study. Eight weeks' treatment with the combination of ACE inhibitor and beta-blocker or the diuretic and beta-blocker produced falls in blood pressure (lying: -8.4 +/- 15.4/ -7.3 +/- 80 mmHg and -6.1 +/- 15.3/ -5.2 +/- 8.8 mmHg [mean +/- SD] for lisinopril and hydrochlorothiazide respectively; standing: -10.2 +/- 14.2/8.2 +/- 9.2 mmHg and -6.8 +/- 14/ -6.3 +/- 10.3 mmHg for lisinopril and hydrochlorothiazide respectively) which were not statistically significantly different. Heart rate was significantly increased on the combination of beta-blocker and diuretic (lying: +4.3 +/- 10.7; standing: +3.2 +/- 10.0 beats/min) compared with a fall on beta-blocker+ACE inhibitor (lying; -0.5 +/- 7.6; standing: -1.5 +/- 7.4). Both therapeutic regimens were equally well tolerated. These results suggest that where patients fail to respond to monotherapy with a beta-blocker the addition of an ACE inhibitor may be as effective as the more traditional option of diuretic therapy.
在一项双盲交叉研究中,38名已接受每日一次50毫克阿替洛尔治疗的患者被随机分配接受氢氯噻嗪(每日一次12.5 - 25毫克)或赖诺普利(每日一次10 - 20毫克)治疗8周。使用ACE抑制剂与β受体阻滞剂组合或利尿剂与β受体阻滞剂组合进行8周治疗后,血压下降(卧位:赖诺普利和氢氯噻嗪分别为-8.4±15.4 / -7.3±8.0 mmHg和-6.1±15.3 / -5.2±8.8 mmHg [平均值±标准差];立位:赖诺普利和氢氯噻嗪分别为-10.2±14.2 / -8.2±9.2 mmHg和-6.8±14 / -6.3±10.3 mmHg),差异无统计学意义。与β受体阻滞剂加ACE抑制剂组合时心率下降(卧位:-0.5±7.6;立位:-1.5±7.4)相比,β受体阻滞剂与利尿剂组合时心率显著增加(卧位:+4.3±10.7;立位:+3.2±10.0次/分钟)。两种治疗方案的耐受性相当。这些结果表明,若患者对β受体阻滞剂单药治疗无反应,加用ACE抑制剂可能与更传统的利尿剂治疗选择一样有效。